Vaccination with Combination DNA and Virus-Like Particles Enhances Humoral and Cellular Immune Responses upon Boost with Recombinant Modified Vaccinia Virus Ankara Expressing Human Immunodeficiency Virus Envelope Proteins

Heterologous prime boost with DNA and recombinant modified vaccinia virus Ankara (rMVA) vaccines is considered as a promising vaccination approach against human immunodeficiency virus (HIV-1). To further enhance the efficacy of DNA-rMVA vaccination, we investigated humoral and cellular immune respon...

Descripción completa

Detalles Bibliográficos
Autores principales: Gangadhara, Sailaja, Kwon, Young-Man, Jeeva, Subbiah, Quan, Fu-Shi, Wang, Baozhong, Moss, Bernard, Compans, Richard W., Amara, Rama Rao, Jabbar, M. Abdul, Kang, Sang-Moo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2017
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5748618/
https://www.ncbi.nlm.nih.gov/pubmed/29257056
http://dx.doi.org/10.3390/vaccines5040052

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5748618/
https://www.ncbi.nlm.nih.gov/pubmed/29257056
http://dx.doi.org/10.3390/vaccines5040052

Ejemplares similares